CCR5 and Parkinson disease: These results suggested that 100 μM ethyl stearate promoted NSCs differentiation into dopaminergic neurons and promoted NSCs migration to lesions by enhancing the expression of CCR5, indicating that NSCs stimulated with 100 μM ethyl stearate might have therapeutic potential as a cell replacement strategy in PD rats.